Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Pain management

New prescribing approach could reduce intravenous opioid exposure

Intravenous opioid doses were reduced by 84% and pain scores improved after researchers trialled a new prescribing standard that favours oral and subcutaneous administration.

A new standard of inpatient opioid prescribing preferring oral and subcutaneous administration may be associated with significant reductions in intravenous opioid exposure, results from a US study show[1].

Researchers compared opioid use from the beginning of a six-month control period to three months after adoption of the new standard, which was initiated alongside education for prescribers and nursing staff on awareness of the subcutaneous route.

They found that intravenous opioid doses were reduced by 84% during the intervention period and combined doses of parenteral opioids, given either intravenously or subcutaneously, were reduced by 55%.

The daily rate of patients administered any parenteral opioid decreased by 57% during the intervention period. The researchers also found that pain scores improved significantly in the intervention group on days four and five after intervention.

Lead author, Adam Ackerman, said: “Intravenous opioids commonly given in hospitals for pain control are an especially dangerous source of exposure.

“Our study suggests that ensuring providers and nurses are made aware of less risky methods of giving opioids can lead to less overall exposure for patients while still controlling their pain.”

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205055

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Opioid tablets, close up

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.